/Companies

Behavidence

5 known investors

Find your way into Behavidence

Sign up to see every warm intro you have to Behavidence

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Behavidence team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Behavidence Enterprise is a clinical decision support platform that uses digital biomarkers to help healthcare professionals make diagnostic and treatment decisions.

Founders & leadership

RCRoy Cohen
Roy CohenCo-FounderRoy Cohen is a neuroscientist with expertise in business development and digital marketing. He is founder and CEO of Behavidence, a clinical decision support platform using digital biomarkers for healthcare diagnostics and treatment decisions, and previously held leadership roles at Vidmob and Wix.

Investors · 5

Funding

SEC filings, press & company announcements

$4.3M disclosed across 1 round · 2022

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Behavidence do?
Behavidence Enterprise is a clinical decision support platform that uses digital biomarkers to help healthcare professionals make diagnostic and treatment decisions.
Who founded Behavidence?
Behavidence was founded by Roy Cohen.
Who are Behavidence's investors?
Behavidence's investors include Fusion VC, GoAhead Ventures, Kicker Ventures, Longevity Venture Partners, Welltech Ventures.
How much funding has Behavidence raised?
Behavidence has disclosed $4.3M raised across 1 round.